Alex Rodriguez Seeks Second Opinion on Injury Says He's Ready to Play

Alex Rodriguez may have yet again put his foot in his mouth as he continues to be a PR, and his team's, nightmare making comments about his injury, and seeing doctors behind the Yankees' back.

New York Yankees team doctors diagnosed the third basemen with a grade 1 quadriceps strain after an MRI. A-Rod confirmed the injury earlier this week, but now he's taken a different tune toward it, and said he should be ready to go Friday. In addition to that, he consulted a non-team doctor.

"To be perfectly honest, I don't see any sort of injury there," said Dr. Michael Gross, a New Jersey physician who called into WFAN sports radio.

Many people are skeptical of the doctor's claims because of his quick willingness to discuss a patient's health publicly.

"Nobody paid me," Gross said to Bergen County Record. "I did it as a favor. … I thought it would be fun. It's my five minutes of fame."

According to Yahoo! Sports, Gross has a shaky past himself. He got into some trouble for "failing to adequately ensure proper patient treatment involving the prescribing of hormones including steroids." Gross also stated that Rodriguez was never one of his patients regarding banned substances.

Essentially, Rodriguez is seeking the advice of a doctor who already may not be trusted, and he is doing so without the blessing of his team, who now has no idea about anything the ballplayer does.

"Contrary to the Basic Agreement," Brian Cashman, general manager of the Yankees said, "Mr. Rodriguez did not notify us at any time that he was seeking a second opinion from any doctor with regard to his quad strain."

It appears A-Rod could just be days or even moments away from some sort of suspension by the MLB. Therefore, he will be barred with out pay for what some are saying 100 games or more.

Rodriguez is a second time offender of banned substances may already feel his chances of credibility and the Hall of Fame are over, so all he has left is to get paid what he is owed, $114 million.